Luis Antonio Corchete Sánchez
Luis Antonio Corchete Sánchez
Bioinformatician, Centro de Investigación del Cáncer de Salamanca (CIC-IBMCC)
Dirección de correo verificada de usal.es
Título
Citado por
Citado por
Año
Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile
B Paiva, T Paino, JM Sayagues, M Garayoa, L San-Segundo, M Martín, ...
Blood, The Journal of the American Society of Hematology 122 (22), 3591-3598, 2013
992013
SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status
L Lopez-Corral, ME Sarasquete, S Beà, R García-Sanz, MV Mateos, ...
Leukemia 26 (12), 2521-2529, 2012
952012
A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control
B Paiva, MB Vidriales, L Rosinol, J Martinez-Lopez, MV Mateos, EM Ocio, ...
Leukemia 27 (10), 2056-2061, 2013
632013
Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies
L López-Corral, LA Corchete, ME Sarasquete, MV Mateos, R García-Sanz, ...
Haematologica 99 (8), 1365-1372, 2014
562014
The cellular origin and malignant transformation of Waldenström macroglobulinemia
B Paiva, LA Corchete, MB Vidriales, R García-Sanz, JJ Perez, ...
Blood 125 (15), 2370-2380, 2015
502015
Phenotypic identification of subclones in multiple myeloma with different chemoresistant, cytogenetic and clonogenic potential
T Paíno, B Paiva, JM Sayagués, I Mota, T Carvalheiro, LA Corchete, ...
Leukemia 29 (5), 1186-1194, 2015
462015
Genomic analysis of high-risk smoldering multiple myeloma
L López-Corral, MV Mateos, LA Corchete, ME Sarasquete, J de la Rubia, ...
haematologica 97 (9), 1439-1443, 2012
462012
Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance
B Paiva, LA Corchete, MB Vidriales, N Puig, P Maiso, I Rodriguez, ...
Blood 127 (15), 1896-1906, 2016
442016
Genomic characterization of liver metastases from colorectal cancer patients
JM Sayagués, LA Corchete, ML Gutiérrez, ME Sarasquete, ...
Oncotarget 7 (45), 72908, 2016
432016
In vivo murine model of acquired resistance in myeloma reveals differential mechanisms for lenalidomide and pomalidomide in combination with dexamethasone
EM Ocio, D Fernández-Lázaro, L San-Segundo, L López-Corral, ...
Leukemia 29 (3), 705-714, 2015
402015
Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development
MC Herrero-Sánchez, C Rodríguez-Serrano, J Almeida, L San Segundo, ...
Journal of hematology & oncology 9 (1), 1-14, 2016
342016
The novel pan-PIM kinase inhibitor, PIM447, displays dual antimyeloma and bone-protective effects, and potently synergizes with current standards of care
T Paíno, A Garcia-Gomez, L González-Méndez, L San-Segundo, ...
Clinical Cancer Research 23 (1), 225-238, 2017
322017
Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under LenDex: a longitudinal analysis
B Paiva, MV Mateos, LI Sanchez-Abarca, N Puig, MB Vidriales, ...
Blood, The Journal of the American Society of Hematology 127 (9), 1151-1162, 2016
29*2016
Genome-wide DNA copy number analysis of acute lymphoblastic leukemia identifies new genetic markers associated with clinical outcome
M Forero-Castro, C Robledo, R Benito, M Abáigar, A África Martín, M Arefi, ...
PLoS One 11 (2), e0148972, 2016
242016
Phenotypic, transcriptomic, and genomic features of clonal plasma cells in light-chain amyloidosis
B Paiva, J Martinez-Lopez, LA Corchete, B Sanchez-Vega, I Rapado, ...
Blood 127 (24), 3035-3039, 2016
232016
Phenotypic, Genomic and Functional Characterization Reveals No Differences between CD138++ and CD138 low Subpopulations in Multiple Myeloma Cell Lines
T Paino, ME Sarasquete, B Paiva, P Krzeminski, L San-Segundo, ...
PloS one 9 (3), e92378, 2014
212014
Effects of IL-8 up-regulation on cell survival and osteoclastogenesis in multiple myeloma
AB Herrero, A García-Gómez, M Garayoa, LA Corchete, JM Hernández, ...
The American journal of pathology 186 (8), 2171-2182, 2016
192016
The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose‐intensive chemotherapy including rituximab
M Forero‐Castro, C Robledo, E Lumbreras, R Benito, ...
British journal of haematology 172 (3), 428-438, 2016
192016
Insights into epigenetic regulation of microRNA-155 expression in multiple myeloma
P Krzeminski, ME Sarasquete, I Misiewicz-Krzeminska, R Corral, ...
Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1849 (3), 353-366, 2015
192015
A next-generation sequencing strategy for evaluating the most common genetic abnormalities in multiple myeloma
C Jiménez, M Jara-Acevedo, LA Corchete, D Castillo, GR Ordóñez, ...
The Journal of Molecular Diagnostics 19 (1), 99-106, 2017
172017
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20